|Other Names||Alpha-aminoadipic semialdehyde synthase, mitochondrial, LKR/SDH, Lysine ketoglutarate reductase, LKR, LOR, Saccharopine dehydrogenase, SDH, AASS|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Bifunctional enzyme that catalyzes the first two steps in lysine degradation. The N-terminal and the C-terminal contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively.|
|Tissue Location||Expressed in all 16 tissues examined with highest expression in the liver|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a bifunctional enzyme that catalyzes thefirst two steps in the mammalian lysine degradation pathway. TheN-terminal and the C-terminal portions of this enzyme containlysine-ketoglutarate reductase and saccharopine dehydrogenaseactivity, respectively, resulting in the conversion of lysine toalpha-aminoadipic semialdehyde. Mutations in this gene areassociated with familial hyperlysinemia.
Sacksteder, K.A., et al. Am. J. Hum. Genet. 66(6):1736-1743(2000)Papes, F., et al. Biochem. J. 344 PT 2, 555-563 (1999) :
If you have any additional inquiries please email technical services at email@example.com.